Thu, Dec 14, 2023
Pfizer used some of its COVID windfall to acquire companies, including a $43 billion deal for cancer drugmaker Seagen it expects to close this week, and began selling a new RSV vaccine.
More >
Sat, Oct 28, 2023
Pfizer Q2 Results: Drug firm Pfizer Ltd reported 52.11 per cent decline in net profit at Rs 148.96 crore for the second quarter ended September 2023.
Wed, Aug 02, 2023
Pfizer June quarter results: Crumbling COVID-19 vaccine and treatment sales chopped Pfizer's second-quarter earnings, but both the drugmaker and Wall Street expect a rebound in the back half of 2023.
Mon, Sep 26, 2016
US drugmaker Pfizer Inc, which has been considering a split into two companies for more than two years, said on Monday it would not do so because the move would not create any shareholder value.
Pfizer on Monday announced that it has completed its transaction deal for the sale of four products to Piramal Enterprises.
Tue, Aug 23, 2016
Fed fund futures imply around a 24% chance of an easing in September, rising to around 50% by December.
Mon, Aug 22, 2016
Pfizer Inc has agreed to buy Medivation Inc which is a biopharmaceutical company focused on developing and commercializing in the treatment for cancer. The merger will be for $81.50 a share in cash for a total enterprise value of approximately $14 billion.
Mon, Aug 15, 2016
"Except for a couple of CNS (central nervous system) products and one pain product, we are not really missing a major portfolio. We are looking at couple of global products, though they have gone all off LOE (loss of exclusivity) to reintroduce them into India, we are also looking at that aspect of this juncture," Pfizer India Managing Director S Sridhar told analysts.
Tue, Aug 02, 2016
Wall Street fell on Tuesday, with the S&P 500 and the Nasdaq having their worst day in more than a month, following weak economic data and losses in technology and consumer discretionary stocks.
Mon, May 30, 2016
After its failure to acquire Allergan, Pfizer recently announced plans to buy Anacor Pharmaceuticals
Mon, May 16, 2016
Pfizer will pay $99.25 per share for Anacor.
Wed, May 04, 2016
Medivation has not yet decided whether it should engage with Pfizer in negotiations and is in discussions with its financial and legal advisers
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
